Sichuan Gowell Pharmaceutical Co., Ltd.

Sichuan Gowell Pharmaceutical Co., Ltd., founded in 2011 with a registered capital of 50 million RMB, is a national high-tech enterprise specializing in the R&D, production, and sales of high-end generic chemical drugs, OMEGA-3 fish oil polyunsaturated fatty acid series medications and health products, and peptide drugs. The company’s product portfolio focuses on the cardiovascular system, urinary and renal systems, digestive system, and anti-infective therapeutics. The company has established a provincial-level enterprise technology center, which encompasses five major R&D platforms: first-to-market and high-end small molecule drug R&D technology, peptide drug R&D ...